M, K. (2026). P2Y12 inhibitor monotherapy vs. DAPT soon after PCI for ACS increased a composite of death or ischemic events at 30 d but not at 1 y. Annals of internal medicine, 179(6), JC66. https://doi.org/10.7326/ANNALS-26-01854-JC
Chicago Style (17th ed.) CitationM, Kesarwani. "P2Y12 Inhibitor Monotherapy Vs. DAPT Soon After PCI for ACS Increased a Composite of Death or Ischemic Events at 30 D but Not at 1 Y." Annals of Internal Medicine 179, no. 6 (2026): JC66. https://doi.org/10.7326/ANNALS-26-01854-JC.
MLA (9th ed.) CitationM, Kesarwani. "P2Y12 Inhibitor Monotherapy Vs. DAPT Soon After PCI for ACS Increased a Composite of Death or Ischemic Events at 30 D but Not at 1 Y." Annals of Internal Medicine, vol. 179, no. 6, 2026, p. JC66, https://doi.org/10.7326/ANNALS-26-01854-JC.